These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1356101)

  • 1. Pharmacokinetics of two oral liquid formulations of oxatomide in children.
    Cavagni G; Caffarelli C; Giordano S; Romanini E; Bertolini P; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):275-6. PubMed ID: 1356101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oxatomide in preterm infants.
    Dani C; Martelli E; Bertini G; Filippi L; Pezzati M; Mazzetti L; Ciuffi M; Zilletti L; Rubaltelli FF
    Drugs Exp Clin Res; 2002; 28(5):207-10. PubMed ID: 12635496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oxatomide given percutaneously to healthy volunteers.
    Benvenuti C; Broggini M; Botta V; Valenti M; Broccali G; Dal Bo L
    Biopharm Drug Dispos; 1992 Oct; 13(7):495-502. PubMed ID: 1362656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxatomide plasma levels in man during chronic dosing.
    Davies BH; Rocchiccioli K
    Pharmatherapeutica; 1983; 3(6):365-9. PubMed ID: 6137831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
    Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
    Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid determination of serum oxatomide levels with on-line precolumn solid-phase extraction.
    Fujii J; Inotsume N; Nakano M; Matsukane I; Higashi A; Matsuda I; Sudo Y; Takahata Y
    J Chromatogr; 1990 Sep; 530(2):469-73. PubMed ID: 1981891
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of oxatomide in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry.
    She X; Wu L; Wei H; Liu W; Chen Y
    Biomed Chromatogr; 2008 Jul; 22(7):746-52. PubMed ID: 18348338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cetirizine in 2- to 6-year-old children.
    Pariente-Khayat A; Rey E; Dubois MC; Vauzelle-Kervroedan F; Pons G; D'athis P; Murat II; Pinelli ME; Saint-Maurice C; Olive G
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):340-4. PubMed ID: 7582385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxatomide modifies methacholine- and exercise-induced bronchoconstriction in asthmatic children.
    Kishida M; Sasamoto A; Saito S; Iikura Y
    Ann Allergy; 1992 Nov; 69(5):455-61. PubMed ID: 1360776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic study of a new benzyl-1 isoquinoline derivative (458 L) after oral administration in men].
    Bargnoux H; Kantelip JP; Bastide M; Duchêne-Marullaz P; Boyer R; Lallouette P; Petit J; Bérger JA
    Therapie; 1990; 45(1):7-11. PubMed ID: 1971461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years.
    Simons FE; Simons KJ
    J Allergy Clin Immunol; 2005 Aug; 116(2):355-61. PubMed ID: 16083790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of atopic dermatitis with oxatomide oral suspension (2.5 mg/ml) in infants].
    Bergonzi F; Mangili G
    Minerva Pediatr; 1997 Dec; 49(12):579-87. PubMed ID: 9577160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride.
    Krishna R; Krishnaswami S; Kittner B; Sankoh AJ; Jensen BK
    Biopharm Drug Dispos; 2004 Dec; 25(9):373-87. PubMed ID: 15517550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment.
    Olsén L; Ingvast-Larsson C; Bondesson U; Broström H; Tjälve H; Larsson P
    J Vet Pharmacol Ther; 2007 Jun; 30(3):194-200. PubMed ID: 17472650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic idiopathic urticaria with topical preparations: controlled study of oxatomide gel versus dechlorpheniramine cream.
    Locci F; Del Giacco GS
    Drugs Exp Clin Res; 1991; 17(8):399-403. PubMed ID: 1688044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of oxatomide, H1-antagonist, on postinfectious chronic cough; a comparison of oxatomide combined with dextromethorphan versus dextromethorphan alone].
    Fujimori K; Suzuki E; Arakawa M
    Arerugi; 1998 Jan; 47(1):48-53. PubMed ID: 9528165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative pharmacokinetics of H1-receptor antagonists.
    Simons FE; Simons KJ; Chung M; Yeh J
    Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.
    Bizikova P; Papich MG; Olivry T
    Vet Dermatol; 2008 Dec; 19(6):348-57. PubMed ID: 18980631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers.
    Spicák V; Dab I; Hulhoven R; Desager JP; Klánová M; de Longueville M; Harvengt C
    Clin Pharmacol Ther; 1997 Mar; 61(3):325-30. PubMed ID: 9084458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxylamine pharmacokinetics following single dose oral administration in children ages 2-17 years.
    Balan G; Thompson GA; Gibb R; Li L; Hull D; Seeck M
    J Clin Pharmacol; 2013 Nov; 53(11):1177-85. PubMed ID: 23868556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.